Literature DB >> 32991971

Danshen (Salvia miltiorrhiza) water extract shows potential neuroprotective effects in Caenorhabditis elegans.

Chee Wah Yuen1, Vikneswaran Murugaiyah2, Nazalan Najimudin3, Ghows Azzam4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Danshen, is a traditional Chinese medicine obtained from the dried root and rhizome of Salvia miltiorrhiza Bunge. It is known to be used for neurological disorder including for Alzheimer's disease (AD). This study uncovers the effect of Danshen water extract on the Alzheimer's disease model of C.elegans.
MATERIAL AND METHODS: The composition of Danshen water extract was determined using (High Performance Liquid Chromatography (HPLC). Then Thioflavin T assay was used to determined if Danshen water extract could prevent the aggregation of amyloid-β peptide (Aβ). Alzheimer's disease C.elegans model was used to determine the effect of Danshen water extract. Finally, the reactive oxygen species (ROS) was determined using the 2,7-dichlorofuorescein diacetate method.
RESULTS: In this study, we found that standardized Danshen water extract that contains danshensu (1.26%), salvianolic acid A (0.35%) and salvianolic acid B (2.21%) are able to bind directly to Aβ and prevents it from aggregating. The IC50 for the inhibition of Aβ aggregation by Danshen water extract was 0.5 mg/ml. In the AD model of C.elegans, Danshen water extract managed to alleviates the paralysis phenotype. Furthermore, the administration of Danshen water extract displayed antioxidant properties toward the Aβ-induced oxidative stress.
CONCLUSIONS: AD is a widespread neurodegenerative disease attributed to the accumulation of extracellular plaques comprising Aβ. Danshen water extract could significantly reduce the progress of paralysis in the AD model of C. elegans, showing promising results with its antioxidant properties. It can be concluded that Danshen water extract could potentially serve as a therapeutic for AD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Caenorhabditis elegans; Danshen; Salvia miltiorrhiza

Mesh:

Substances:

Year:  2020        PMID: 32991971     DOI: 10.1016/j.jep.2020.113418

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.

Authors:  Weifan Xu; Yiping Jiang; Nani Wang; Huanhuan Bai; Shengyan Xu; Tianshuang Xia; Hailiang Xin
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 2.  Natural Bioactive Products and Alzheimer's Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models.

Authors:  María D Navarro-Hortal; Jose M Romero-Márquez; Safa Osta; Victoria Jiménez-Trigo; Pedro Muñoz-Ollero; Alfonso Varela-López
Journal:  Diseases       Date:  2022-05-13

3.  Cryptotanshinone ameliorates MPP+-induced oxidative stress and apoptosis of SH-SY5Y neuroblastoma cells: the role of STAT3 in Parkinson's disease.

Authors:  Quanzhe Wang; Yan Liu
Journal:  Metab Brain Dis       Date:  2022-04-09       Impact factor: 3.655

Review 4.  Oxidation and Antioxidation of Natural Products in the Model Organism Caenorhabditis elegans.

Authors:  An Zhu; Fuli Zheng; Wenjing Zhang; Ludi Li; Yingzi Li; Hong Hu; Yajiao Wu; Wenqiang Bao; Guojun Li; Qi Wang; Huangyuan Li
Journal:  Antioxidants (Basel)       Date:  2022-04-02

5.  A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer's Disease.

Authors:  Bo Li; Yu-Rui Wu; Lan Li; Yu Liu; Zhu-Yun Yan
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

Review 6.  Traditional chinese medicine to prevent and treat diabetic erectile dysfunction.

Authors:  Yanfei Feng; Tianhao Shi; Yuli Fu; Bodong Lv
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.